Sylvamo Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $3.3B-12.6% YoYTTM through 30 Jun 2026
Net Income $76M-74.8% YoYTTM through 30 Jun 2026
Free Cash Flow -$11MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | 10.7% |
| Operating Margin | 5.3% |
| Net Margin | 2.3% |
Returns
8.0%ROE
2.6%ROA
4.5%ROIC
Balance Sheet Health
Debt / Equity0.94x
Current Ratio1.45x
Net Debt$791M
Cash & Equivalents$123M
Quality Metrics
Altman Z-Score3.15
Piotroski F-Score5 / 9
FCF Margin-0.3%
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $3.4B
Diluted EPS$1.87TTMFY2025: $3.24
Dividend
$0.90Per share, FY20262.44%Yield
Capital Allocation
Capex Intensity6.7%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| North America | View details2026 is a transition year due to the termination of the Riverdale supply agreement and planned Eastover mill outages. | ||
| Europe | View detailsImpacted by reliability issues and cyclical industry downturns. | ||
| Latin America | View detailsImplementing price increases of 7% in the second quarter of 2026. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.